Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic ResponseJaffer A. Ajani, Tyvin A. Rich, Kathryn Winter et al.|Journal of Clinical Oncology|2006Cited by 385
Metastatic Pancreatic Cancer: ASCO Guideline UpdateDavendra Sohal, Daniel A. Laheru, Philip A. Philip et al.|Journal of Clinical Oncology|2020Cited by 287
Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta‐analysisLeila T. Tchelebi, Nicholas G. Zaorsky, Eric J. Lehrer et al.|Cancer|2020Cited by 120
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaEugene J. Koay, Jason B. Fleming, Yeon‐Ju Lee et al.|Clinical Cancer Research|2018Cited by 111
Localized Adenocarcinoma of the Pancreas: The Rationale for Preoperative ChemoradiationJeffrey D. Wayne, Douglas B. Evans, Eddie K. Abdalla et al.|The Oncologist|2002Cited by 78